Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP

Marc Töteberg-Harms, James Vm Hanson, Jens Funk, Marc Töteberg-Harms, James Vm Hanson, Jens Funk

Abstract

Background: Cataract surgery combined with excimer laser trabeculotomy (phaco-ELT) can reduce intraocular pressure (IOP). The aim of this study was to evaluate the effect of phaco-ELT on IOP in patients as a function of preoperative IOP.

Methods: Patients with open-angle glacuoma or ocular hypertension who received phaco-ELT between 01/2008 and 10/2009 were included. Patients were assigned based on preoperative IOP either to the study group (≤21 mmHg) or control group (>21 mmHg) in this IRB-approved, prospective, consecutive case series. Visual Acuity, IOP, and number of anti-glaucoma drugs (AGD) were recorded at baseline and 12 months after phaco-ELT. Any postoperative complications were also recorded.

Results: 64 eyes of 64 patients (76.5 ± 9.4 years) were included. Baseline IOP was 19.8 ± 5.3 mmHg (AGD 2.4 ± 1.1) for all eyes, 16.5 ± 2.9 mmHg (AGD 2.5 ± 1.0) for the study group, and 25.8 ± 2.9 mmHg (AGD 2.2 ± 1.4) for the control group. Across the two groups, IOP was reduced by 4.5 ± 5.9 mmHg (-23.0%, p < 0.001) and AGD by 0.9 ± 1.5 (-38.9%, p < 0.001). For the study group IOP was reduced by 1.9 ± 4.4 mmHg (-11. 5 %, p = 0.012) and AGD by 1.1 ± 1.4 (-42.9%, p < 0.001), and for the control group by 9.5 ± 5.4 mmHg (-36.6%, p < 0.001) and AGD by 0.7 ± 1.6 (-29.5%, p = 0.085). There were no serious postoperative complications such as endophthalmitis, significant hyphema, or a severe fibrinous reaction of the anterior chamber.

Conclusions: IOP remained significantly reduced from baseline 12 months after phaco-ELT regardless of preoperative IOP levels, with no major complications. The IOP reduction remained constant over the entire follow-up. Hence, phaco-ELT can be considered in glaucoma and ocular hypertensive patients whenever cataract surgery is performed, in order to further reduce IOP or to reduce the requirement for IOP-reducing medications.

Trial registration: ClinicalTrials.gov NCT01194310.

Figures

Figure 1
Figure 1
Under endoscopic guidance, ten laser spots were applied into the trabecular meshwork spread over an area of 90°. At the point of laser transmission, the probe is in direct contact with the trabecular meshwork.
Figure 2
Figure 2
After laser application a formation of bubbles could be seen, together with a small retrograde bleeding.

References

    1. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi: 10.1001/archopht.120.10.1268.
    1. Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89(9):991–998.
    1. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498–505.
    1. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487–497.
    1. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;13(4):429–440.
    1. Palmberg P. Risk factors for glaucoma progression: Where does intraocular pressure fit in? Arch Ophthalmol. 2001;119(6):897–898. doi: 10.1001/archopht.119.6.897.
    1. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673–679.
    1. Singh K, Mehta K, Shaikh NM, Tsai JC, Moster MR, Budenz DL, Greenfield DS, Chen PP, Cohen JS, Baerveldt GS. et al.Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology. 2000;107(12):2305–2309. doi: 10.1016/S0161-6420(00)00391-2.
    1. Bill A, Svedbergh B. Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm-an attempt to localize the main resistance to outflow of aqueous humor in man. Acta Ophthalmol (Copenh) 1972;50(3):295–320.
    1. Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res. 1992;54(6):879–883. doi: 10.1016/0014-4835(92)90151-H.
    1. Vogel MH, Schildberg P. [Histological findings after experimental laser-trabeculo-puncture (author's transl)] Klin Monbl Augenheilkd. 1973;163(3):353–358.
    1. Kaufmann R, Hibst R. Pulsed Er: YAG- and 308 nm UV-excimer laser: an in vitro and in vivo study of skin-ablative effects. Lasers Surg Med. 1989;9(2):132–140. doi: 10.1002/lsm.1900090208.
    1. Muller-Stolzenburg N, Muller GJ. Transmission of 308 nm excimer laser radiation for ophthalmic microsurgery-medical, technical and safety aspects. Biomed Tech (Berl) 1989;34(6):131–138.
    1. Vogel M, Scheurer G, Neu W, Dressel M, Gerhardt H. [Ablation of the trabecular meshwork] Klin Monbl Augenheilkd. 1990;197(3):250–253.
    1. Jahn R, Lierse W, Neu W, Jungbluth KH. Macroscopic and microscopic findings after excimer laser treatment of different tissue. J Clin Laser Med Surg. 1992;10(6):413–418.
    1. Vogel M, Lauritzen K, Quentin CD. [Targetted ablation of the trabecular meshwork with excimer laser in primary open-angle glaucoma] Ophthalmologe. 1996;93(5):565–568. doi: 10.1007/s003470050040.
    1. Vogel M, Lauritzen K. [Selective excimer laser ablation of the trabecular meshwork. Clinical results] Ophthalmologe. 1997;94(9):665–667. doi: 10.1007/s003470050180.
    1. Walker R, Specht H. [Theoretical and physical aspects of excimer laser trabeculotomy (ELT) ab interno with the AIDA laser with a wave length of 308 mm] Biomed Tech (Berl) 2002;47(5):106–110.
    1. Babighian S, Rapizzi E, Galan A. Efficacy and safety of ab interno excimer laser trabeculotomy in primary open-angle glaucoma: two years of follow-up. Ophthalmologica. 2006;220(5):285–290. doi: 10.1159/000094616.
    1. Pache M, Wilmsmeyer S, Funk J. [Laser surgery for glaucoma: excimer-laser trabeculotomy] Klin Monbl Augenheilkd. 2006;223(4):303–307. doi: 10.1055/s-2005-858861.
    1. Wilmsmeyer S, Philippin H, Funk J. Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(6):670–676. doi: 10.1007/s00417-005-0136-y.
    1. Herdener S, Pache M. [Excimer laser trabeculotomy: minimally invasive glaucoma surgery] Ophthalmologe. 2007;104(8):730–732. doi: 10.1007/s00347-007-1598-6.
    1. Taliaferro K. Excimer laser trabeculotomy. Ophthalmologica. 2008;222(6):424. doi: 10.1159/000161558.
    1. Babighian S, Caretti L, Tavolato M, Cian R, Galan A. Excimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trial. Eye (Lond) 2010;24(4):632–638. doi: 10.1038/eye.2009.172.
    1. Shaffer RN. A suggested anatomic classification to define the pupillary block glaucomas. Invest Ophthalmol. 1973;12(7):540–542.
    1. Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30(2):287–290. doi: 10.1016/j.jcrs.2004.01.014.
    1. Holladay JT, Prager TC. Mean visual acuity. Am J Ophthalmol. 1991;111(3):372–374.
    1. Gedde SJ, Schiffman JC, Feuer WJ, Parrish RK 2nd, Heuer DK, Brandt JD. The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol. 2005;140(2):275–287.
    1. Huang S, Yu M, Feng G, Zhang P, Qiu C. Histopathological study of trabeculum after excimer laser trabeculectomy ab interno. Yan Ke Xue Bao. 2001;17(1):11–15.
    1. Neuhann T, Scharrer A, Haefliger E. Excimer laser trabecular ablation ab interno (ELT) in the treatment of chronic open-angle glaucoma. A pilot study. Ophthalmo-Chirurgie. 2001;13:3–7.
    1. Berlin MS, Rajacich G, Duffy M, Grundfest W, Goldenberg T. Excimer laser photoablation in glaucoma filtering surgery. Am J Ophthalmol. 1987;103(5):713–714.
    1. Berlin MS, Yoo PH, Ahn RJ. The role of laser sclerostomy in glaucoma surgery. Curr Opin Ophthalmol. 1995;6(2):102–114. doi: 10.1097/00055735-199504000-00016.
    1. Toteberg-Harms M, Ciechanowski PP, Hirn C, Funk J. [One-year results after combined cataract surgery and excimer laser trabeculotomy for elevated intraocular pressure] Ophthalmologe. 2011;108(8):733–738. doi: 10.1007/s00347-011-2337-6.
    1. Shingleton BJ, Gamell LS, O'Donoghue MW, Baylus SL, King R. Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999;25(7):885–890. doi: 10.1016/S0886-3350(99)00107-8.
    1. Hudovernik M, Pahor D. Intraocular pressure after phacoemulsification with posterior chamber lens implantation in open-angle glaucoma. Klin Monbl Augenheilkd. 2003;220(12):835–839.
    1. Kim DD, Doyle JW, Smith MF. Intraocular pressure reduction following phacoemulsification cataract extraction with posterior chamber lens implantation in glaucoma patients. Ophthalmic Surg Lasers. 1999;30(1):37–40.
    1. Dooley I, Charalampidou S, Malik A, Loughman J, Molloy L, Beatty S. Changes in intraocular pressure and anterior segment morphometry after uneventful phacoemulsification cataract surgery. Eye (Lond) 2010;24(4):519–526. doi: 10.1038/eye.2009.339. quiz 527.
    1. Shrivastava A, Singh K. The effect of cataract extraction on intraocular pressure. Curr Opin Ophthalmol. 2010;21(2):118–122. doi: 10.1097/ICU.0b013e3283360ac3.
    1. Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, Kass MA. Reduction in Intraocular Pressure after Cataract Extraction: The Ocular Hypertension Treatment Study. Ophthalmology. 2012;11(9):1826–31.
    1. Mills KB. Trabeculectomy: a retrospective long-term follow-up of 444 cases. Br J Ophthalmol. 1981;65(11):790–795. doi: 10.1136/bjo.65.11.790.
    1. Khalili MA, Diestelhorst M, Krieglstein GK. [Long-term follow-up of 700 trabeculectomies] Klin Monbl Augenheilkd. 2000;217(1):1–8. doi: 10.1055/s-2000-10376. discussion 9.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅